Actavia Life Sciences (OTC:RASP) Stock, Quote.Headers.trade-ideas

Actavia Life Sciences Inc is a clinical-stage biotechnology company focused on targeted drugs to treat diseases in oncology and immunology, mainly focusing on the treatment of leukemia. Its primary indication is Acute Myeloid Leukemia (AML), which may be fatal within weeks to months, has about a 5-year survival rate of only about 25% and very poor prospects for the long-term survival of patients.

ACTAVIA LIFE SCIENCES INC by Actavia Life Sciences, Inc.

Actavia Life Sciences Inc

RASPBERRY PI HLDGS PLC by RASPBERRY PI HLDGS PLC

Comments

Actavia Life Sciences

Actavia Life Sciences (OTC:RASP) Stock, Quote.Headers.trade-ideas

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell